Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J V Watson

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|September 1, 1989
Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancerS A Morgan, J V Watson, P R Twentyman, et al.
Cell and Tissue Kinetics|January 1, 1975
Changes in cell proliferation kinetics occurring during the life history of monolayer cultures of a mouse tumour cell lineP R Twentyman, J V Watson, N M Bleehen, et al.
Biochemical Pharmacology|November 1, 1990
Mitoxantrone-DNA binding and the induction of topoisomerase II associated DNA damage in multi-drug resistant small cell lung cancer cellsP J Smith, S A Morgan, M E Fox, et al.
American Journal of Obstetrics and Gynecology|August 1, 1990
Flow cytometric quantitation of tumor-associated antigens in solid tumorsP A van Dam, J H Shepherd, D G Lowe, et al.
British Journal of Cancer|May 1, 1989
The expression of c-myc related to the proliferation and transformation of rat liver-derived epithelial cellsS Sinha, G E Neal, R F Legg, et al.
Anticancer Research|November 1, 1991
Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patientsV Sundaresan, J G Reeve, B Wilson, et al.
Obstetrics and Gynecology|April 1, 1992
Flow cytometric measurement of cell components other than DNA: virtues, limitations, and applications in gynecologic oncologyP A van Dam, J V Watson, D G Lowe, et al.
Oncogene|June 1, 1989
Regulation of cell cycle duration by c-myc levelsJ Karn, J V Watson, A D Lowe, et al.
The British Journal of Surgery|September 1, 1991
c-myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumoursD A Rew, I Taylor, H Cox, et al.
International Journal of Cancer|September 15, 1989
Oestrogen potentiates topoisomerase-II-mediated cytotoxicity in an activated subpopulation of human breast cancer cells: implications for cytotoxic drug resistance in solid tumoursR J Epstein, P J Smith, J V Watson, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|September 1, 1989
Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancerS A Morgan, J V Watson, P R Twentyman, et al.
Cell and Tissue Kinetics|January 1, 1975
Changes in cell proliferation kinetics occurring during the life history of monolayer cultures of a mouse tumour cell lineP R Twentyman, J V Watson, N M Bleehen, et al.
Biochemical Pharmacology|November 1, 1990
Mitoxantrone-DNA binding and the induction of topoisomerase II associated DNA damage in multi-drug resistant small cell lung cancer cellsP J Smith, S A Morgan, M E Fox, et al.
American Journal of Obstetrics and Gynecology|August 1, 1990
Flow cytometric quantitation of tumor-associated antigens in solid tumorsP A van Dam, J H Shepherd, D G Lowe, et al.
British Journal of Cancer|May 1, 1989
The expression of c-myc related to the proliferation and transformation of rat liver-derived epithelial cellsS Sinha, G E Neal, R F Legg, et al.
Anticancer Research|November 1, 1991
Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patientsV Sundaresan, J G Reeve, B Wilson, et al.
Obstetrics and Gynecology|April 1, 1992
Flow cytometric measurement of cell components other than DNA: virtues, limitations, and applications in gynecologic oncologyP A van Dam, J V Watson, D G Lowe, et al.
Oncogene|June 1, 1989
Regulation of cell cycle duration by c-myc levelsJ Karn, J V Watson, A D Lowe, et al.
The British Journal of Surgery|September 1, 1991
c-myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumoursD A Rew, I Taylor, H Cox, et al.
International Journal of Cancer|September 15, 1989
Oestrogen potentiates topoisomerase-II-mediated cytotoxicity in an activated subpopulation of human breast cancer cells: implications for cytotoxic drug resistance in solid tumoursR J Epstein, P J Smith, J V Watson, et al.
Pageof 12